1. Home
  2. AIRG vs HOWL Comparison

AIRG vs HOWL Comparison

Compare AIRG & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$4.05

Market Cap

52.7M

Sector

Technology

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

46.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRG
HOWL
Founded
1995
2017
Country
United States
United States
Employees
106
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
46.7M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
AIRG
HOWL
Price
$4.05
$1.01
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $8.88
N/A
AVG Volume (30 Days)
59.7K
★ 455.5K
Earning Date
11-10-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.65
18.40
EPS
N/A
★ N/A
Revenue
★ $51,779,000.00
N/A
Revenue This Year
$9.20
N/A
Revenue Next Year
$17.61
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.00
$0.27
52 Week High
$7.66
$1.83

Technical Indicators

Market Signals
Indicator
AIRG
HOWL
Relative Strength Index (RSI) 35.30 57.50
Support Level $3.83 $0.86
Resistance Level $4.28 $1.14
Average True Range (ATR) 0.20 0.05
MACD 0.02 -0.00
Stochastic Oscillator 24.45 50.82

Price Performance

Historical Comparison
AIRG
HOWL

About AIRG Airgain Inc.

Airgain Incs a provider of advance wireless connectivity solutions. It is focused on delivering high-performance, cost-effective, and energy-efficient wireless solutions that enable rapid market deployment. It mission is to connect the world through integrated, and optimized wireless solutions. Companies' diverse product portfolio serves three primary markets: enterprise, automotive, and consumer. While historically recognized for high-performance radio frequency (RF) components, Airgain is increasingly delivering integrated, system-level connectivity solutions that combine hardware, software, and cloud management. The enterprise market demands reliable wireless access across diverse settings, including smart cities, campuses, stadiums, transportation hubs, utilities, buildings suburbs.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: